Business Context and Reporting Period
This Form 6-K filing by NewGenIvf Group Limited covers the month of April 2025, with the report dated April 16, 2025. The Company is a foreign private issuer headquartered in Bangkok, Thailand, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate action regarding the Company's capital structure.
Material Changes
The Board of Directors approved a reverse stock split of all issued and unissued shares (Class A Ordinary Shares, Class B Ordinary Shares, and preferred shares) at a ratio of one (1) share for ten (10) shares. Key details include:
- Effective Date: Expected on or around May 2, 2025.
- Share Count Reduction: Outstanding Class A Ordinary Shares will decrease from 7,508,094 to approximately 750,809.
- Fractional Shares: No fractional shares will be issued; shareholders entitled to fractions will receive one full post-split share.
- Derivatives Adjustment: All outstanding options, warrants, and convertible securities will be adjusted by dividing the exercisable share count by ten.
- Corporate Governance: The Company will amend and restate its memorandum and articles of association to reflect the adjusted authorized share count.
Guidance, Outlook, and Risks
Purpose: The reverse stock split is intended to ensure compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market.
Trading Status: Class A Ordinary Shares are expected to begin trading on a post-split basis on or around May 2, 2025.
Risks and Contingencies: The filing does not explicitly detail other risks or contingencies beyond the necessity of the split to maintain listing status. Management commentary is limited to the mechanics and rationale of the split.
Investor Verification Checklist
- Confirm the exact effective date of the reverse stock split (expected May 2, 2025) via Nasdaq announcements.
- Verify the adjusted number of shares held in brokerage accounts post-split.
- Review the terms of any outstanding options or warrants to confirm the adjusted exercise price and share count.
- Monitor the stock price to ensure it meets the $1.00 minimum bid price requirement following the split.
- Check for the filing of the Second Amended and Restated Memorandum and Articles of Association (Exhibit 1.1).